Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms

Current Opinion in Pharmacology

Volumn 13, Issue 2, 2013, Pages 180-185

  Chen, Xiaofeng ^a   Lu, Hong ^a   Rateri, Debra L ^a   Cassis, Lisa A ^b   Daugherty, Alan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FIBRILLIN 1; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; RENIN; RENIN INHIBITOR; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ABDOMINAL AORTA ANEURYSM; AORTA ANEURYSM; CELL INTERACTION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE DRUG DOSE; THORACIC AORTA ANEURYSM; VASODILATATION;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84879414073     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.01.002     Document Type: Review

References (35)

1. H. Lu, D.L. Rateri, D. Bruemmer, L.A. Cassis, and A. Daugherty Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms Clin Sci 123 2012 531 543
2. P.K. Mehta, and K.K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol 292 2007 C82 C97
3. M.E. Lindsay, and H.C. Dietz Lessons on the pathogenesis of aneurysm from heritable conditions Nature 473 2011 308 316
4. V. Subramanian, J. Golledge, E.B. Heywood, D. Bruemmer, and A. Daugherty Regulation of peroxisome proliferator-activated receptor-gamma by angiotensin II via transforming growth factor-beta1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells Arterioscler Thromb Vasc Biol 32 2012 397 405
5. G. Liu, E. Espinosa, B.S. Oemar, and T.F. Luscher Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-beta 1 Arterioscler Thromb Vasc Biol 17 1997 1251 1257 (Pubitemid 27329847)
6. J. Schultz Jel, S.A. Witt, B.J. Glascock, M.L. Nieman, P.J. Reiser, S.L. Nix, T.R. Kimball, and T. Doetschman TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II J Clin Invest 109 2002 787 796 (Pubitemid 34263155)
7. V.V. Petrov, R.H. Fagard, and P.J. Lijnen Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts J Renin Angiotensin Aldosterone Syst 1 2000 342 352
8. X.H. Zhang, B. Zheng, C. Gu, J.R. Fu, and J.K. Wen TGF-beta1 downregulates AT1 receptor expression via PKC-delta-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-gamma association with KLF4 Arterioscler Thromb Vasc Biol 32 2012 1015 1023
9. B. Schmierer, and C.S. Hill TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility Nat Rev Mol Cell Biol 8 2007 970 982 (Pubitemid 350174642)
10. A. Bobik Transforming growth factor-betas and vascular disorders Arterioscler Thromb Vasc Biol 26 2006 1712 1720 (Pubitemid 44305323)
11. J. Rodriguez-Vita, E. Sanchez-Lopez, V. Esteban, M. Ruperez, J. Egido, and M. Ruiz-Ortega Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism Circulation 111 2005 2509 2517 (Pubitemid 40696140)
12. W. Wang, X.R. Huang, E. Canlas, K. Oka, L.D. Truong, C. Deng, N.A. Bhowmick, W. Ju, E.P. Bottinger, and H.Y. Lan Essential role of Smad3 in angiotensin II-induced vascular fibrosis Circ Res 98 2006 1032 1039
13. A. Daugherty, D.L. Rateri, I.F. Charo, A.P. Owens, D.A. Howatt, and L.A. Cassis Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice Clin Sci (Lond) 118 2010 681 689
14. D.L. Rateri, D.A. Howatt, J.J. Moorleghen, R. Charnigo, L.A. Cassis, and A. Daugherty Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm Am J Pathol 179 2011 1542 1548
15. D.L. Rateri, J.J. Moorleghen, A. Balakrishnan, A.P. Owens 3rd, D.A. Howatt, V. Subramanian, A. Poduri, R. Charnigo, L.A. Cassis, and A. Daugherty Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice Circ Res 108 2011 574 581
16. Y. Wang, H. Ait-Oufella, O. Herbin, P. Bonnin, B. Ramkhelawon, S. Taleb, J. Huang, G. Offenstadt, C. Combadiere, and L. Renia TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice J Clin Invest 120 2010 422 432
17. V. Marque, P. Kieffer, B. Gayraud, I. Lartaud-Idjouadiene, F. Ramirez, and J. Atkinson Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome Arterioscler Thromb Vasc Biol 21 2001 1184 1189 (Pubitemid 34215148)
18. J.P. Habashi, D.P. Judge, T.M. Holm, R.D. Cohn, B.L. Loeys, T.K. Cooper, L. Myers, E.C. Klein, G. Liu, and C. Calvi Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome Science 312 2006 117 121
19. J.P. Habashi, J.J. Doyle, T.M. Holm, H. Aziz, F. Schoenhoff, D. Bedja, Y. Chen, A.N. Modiri, D.P. Judge, and H.C. Dietz Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism Science 332 2011 361 365
20. W. Xiong, T. Meisinger, R. Knispel, J.M. Worth, and B.T. Baxter MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome Circ Res 110 2012 e92 e101
21. D. Gomez, A. Coyet, V. Ollivier, X. Jeunemaitre, G. Jondeau, J.B. Michel, and R. Vranckx Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms Cardiovasc Res 89 2011 446 456
22. D. Langlois, M. Hneino, L. Bouazza, A. Parlakian, T. Sasaki, G. Bricca, and J.Y. Li Conditional inactivation of TGF-beta type II receptor in smooth muscle cells and epicardium causes lethal aortic and cardiac defects Transgenic Res 19 2010 1069 1082
23. M. Jaffe, C. Sesti, I.M. Washington, L. Du, N. Dronadula, M.T. Chin, D.B. Stolz, E.C. Davis, and D.A. Dichek Transforming growth factor-beta signaling in myogenic cells regulates vascular morphogenesis, differentiation, and matrix synthesis Arterioscler Thromb Vasc Biol 32 2012 e1 e11
24. H.H. Yang, J.M. Kim, E. Chum, C. van Breemen, and A.W. Chung Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome J Thorac Cardiovasc Surg 140 2010 305-312.e2
25. E. Moltzer, L. te Riet, S.M. Swagemakers, P.M. van Heijningen, M. Vermeij, R. van Veghel, A.M. Bouhuizen, J.H. van Esch, S. Lankhorst, and N.W. Ramnath Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade PLoS One 6 2011 e23411
26. T.M. Holm, J.P. Habashi, J.J. Doyle, D. Bedja, Y. Chen, C. van Erp, M.E. Lindsay, D. Kim, F. Schoenhoff, and R.D. Cohn Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice Science 332 2011 358 361
27. J. Sadoshima Novel AT(1) receptor-independent functions of losartan Circ Res 90 2002 754 756 (Pubitemid 34633889)
28. D.R. Merk, J.T. Chin, B.A. Dake, L. Maegdefessel, M.O. Miller, N. Kimura, P.S. Tsao, C. Iosef, G.J. Berry, and F.W. Mohr miR-29b participates in early aneurysm development in Marfan syndrome Circ Res 110 2012 312 324
29. H. Nistala, S. Lee-Arteaga, L. Carta, J.R. Cook, S. Smaldone, G. Siciliano, A.N. Rifkin, H.C. Dietz, D.B. Rifkin, and F. Ramirez Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome Hum Mol Genet 19 2010 4790 4798
30. H. Lu, A. Balakrishnan, D.A. Howatt, C. Wu, R. Charnigo, G. Liau, L.A. Cassis, and A. Daugherty Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis Br J Pharmacol 165 2012 2000 2008
31. B.S. Brooke, J.P. Habashi, D.P. Judge, N. Patel, B. Loeys, and H.C. Dietz 3rd Angiotensin II blockade and aortic-root dilation in Marfan's syndrome N Engl J Med 358 2008 2787 2795 (Pubitemid 351930853)
32. E. Moltzer, J. Essers, J.H. van Esch, J.W. Roos-Hesselink, and A.H. Danser The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications Pharmacol Ther 131 2011 50 60
33. J.M. Spin, M. Hsu, J. Azuma, M.M. Tedesco, J.S. Dyer, L. Maegdefessel, R.L. Dalman, and P.S. Tsao Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm Physiol Genomics 43 2011 993 1003
34. V.L. King, A.Y. Lin, F. Kristo, T.J. Anderson, N. Ahluwalia, G.J. Hardy, A.P. Owens 3rd, D.A. Howatt, D. Shen, and A.M. Tager Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture Circulation 119 2009 426 435
35. A. Klink, J. Heynens, B. Herranz, M.E. Lobatto, T. Arias, H.M. Sanders, G.J. Strijkers, M. Merkx, K. Nicolay, and V. Fuster In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging J Am Coll Cardiol 58 2011 2522 2530